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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S112patient, the injured knee and the unharmed knee showed no difference in
varus angle. In 5 patients the measurement of telomere lengths showed
that telomere length of lateral femoral condyle >ACL >medial femoral
condyle; in one patient the measure showed telomere length of medial
femoral condyle >ACL > lateral femoral condyle.
Conclusions: From test 1, we found expression of asporin in ACL increased
in the OA patients, it suggested degeneration of ACL in the OA patients.
From test 2, we found that ACL injury would increase the varus angles of
the knee. From test 3, we found that senescent degree in osteoarthritis
knee is medial femoral condyle >ACL > lateral femoral condyle. We
infered that ACL might degenerate or get injured at ﬁrst, and then led to
knee varus, and led to osteoarthritis at last.ĂBone Biology
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FSTL3 MEDIATES EXERCISE-DRIVEN BONE FORMATION.
P. Perera. The Ohio State Univ., Columbus, OH, USA
Objective: Exercise promotes bone remodeling through well-coordinated
biochemical events. This is evident by the observations that bone forms in
response to mechanical loading and resorbs following sustained unload-
ing. Despite this well demonstrated phenomenon, how exercise drives the
mechanoresponsiveness in bone is still elusive. Here, we provide
evidences that Follistatin-like3 (FSTL3) could be a mechanoresponsive
protein that that takes part in the exercise-driven bone formation.
Methods: Institutional Animal Care and Use Committee at OSU approved
all experimental protocols. Female Sprague Dawley rats (12-14 wks, n¼10),
wild-type (WT, 10-12 wks, n¼10) or homozygous FSTL3-/- C57Bl/6 mice
(10-12 wks, n¼10) were subjected to exercise by treadmill walking at 12
M/min (rats) or 8 M/min (mice) for 45 min/day. Following 0, 2, 5 or 15 days
of exercise, animals were sacriﬁced and gene expression was analyzed by
quantitative real time polymerase chain reaction (qrtPCR), Western blots,
or immunohistochemistry of the trabecular bone/bone marrow at the
distal ends of femurs. Bone mineral apposition rates of wild type or FSTL3-
null mice were assessed using two ﬂuorochromes, Calcein and Alizarin
complexones injected on day 3 and 12, respectively, during the total
exercise period of 15 days. On day 15, femurs of the mice were excised,
acrylamide embedded, sectioned, and subjected to ﬂuorescence micros-
copy to examine bone remodeling. Statistical analysis was performed by
one-way ANOVA with Tukey's post hoc or T-test.
Results: Gene expression for Fstl3, Follistatin (Fst), Inhibin-Alpha (Inha),
Inhibin-Beta-A (Inhba), and -Beta-B (Inhbb) by qrtPCR revealed that
treadmill walking dramatically stimulated Fstl3 mRNA expression in the
trabecular bone and bonemarrowcells, reachingw6 fold increase on day 2
(p<0.05) and declining by day 5, in rats and mice. However, the expression
of Inha, Inhba, and Inhbb was unchanged (Fig 1A). In parallel, a robust
increase in FSTL3 expression was observed in cells adjacent to trabecular
bone, and in osteocalcin positive osteocytes located in cortical bone (Fig
1B). When Fstl3+/+ or Fstl3-/- mice were subjected to treadmill walking for
15 consecutive days, and injectedwith Calcein (day 3) and Alizarin (day 12)
bone incorporation revealed limited bone deposition in both groups of
non-exercised control mice. However, Fstl3+/+ mice when subjected to
treadmill walking demonstrated a signiﬁcant increase in bone deposition
on the periosteal surface of the femur together with increase in the total
mineral apposition rate (MAR;w50% increase, p< 0.05). Similar treatment
failed to induce exercise-induced bone formation and MAR increase in
Fstl3-/- mice. Furthermore, FSTL3 null mice exhibited weaker femurs
(ultimate strength FSTL3+/+ 3.20.4% vs. FSTL3-/- 2.40.3%, p<0.003) and
brittle bones (fracture strain FSTL3+/+ 7.73.4% vs. FSTL3-/- 51.3%, n ¼ 7,
p ¼ 0.037). Interestingly, circulating levels of FSTL3 increased in mice,
humans and rats following 2 days (5.21.3) and 5 days (6.41.1 fold) of
exercise, indicating a requirement of FSTL3 for the adaptive responses of
the bone to mechanical loading.
Conclusions: Overall, the data suggest that FSTL3 is the ﬁrst molecule
identiﬁed that might be critical for bone formation and strengthening in
response to mechanical loading of bones. This is evident by observations
that genomic deletion of FSTL3 abolishes load-dependent bone formation,
weakening of bones, and failure of upregulation of genes associated with
bone deposition. The identiﬁcation of FSTL3 as a mechanoresponsiveprotein provides a new paradigm for investigating exercise-driven bone
formation and its use as a target to develop therapeutic drugs for treating
bone diseases.
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A SPECIFIC SUBTYPE OF OSTEOCLASTS SECRETE FACTORS INDUCING
BONE FORMATION
K. Henriksen 1, K.V. Andreassen 1, C.S. Thudium1, N.S. Gudmann 1, A.C. Bay-
Jensen 1, I. Moscatelli 2, J. Richter 2, M.A. Karsdal 1, A.V. Neutzsky-
Wulff 1. 1Nordic BioSci. A/S, Herlev, Denmark; 2Dept. of Molecular Med.
and Gene Therapy, Lund Strategic Ctr. for Stem Cell Biology, Lund, Sweden
Purpose: Osteoclasts are known to be important for the coupling process
between bone resorption and formation, at least partially by secretion of
bone anabolic factor(s), a phenomenon which could be involved in the
subchondral plate thickening in OA .
The aims of this study were to address whether osteoclasts are the only
source of anabolic factors, and how the ability to resorb, as well as how
different matrices affect the release of bone anabolic factors from mature
resorbing osteoclasts.
Methods: Human monocytes were isolated from cord blood or periph-
eral blood and differentiated into mature osteoclasts by treatment with
M-CSF and RANKL. Conditioned medium was collected from macro-
phages, pre-osteoclasts, and mature functional and non-resorbing
osteopetrotic osteoclasts on either bone, plastic, decalciﬁed bone or
dentine. Osteoclasts on bone and plastic were treated with vehicle or
diphyllin, E64 or GM6001. Conditioned medium (CM) and corresponding
non-conditioned medium (non-CM) was collected and pooled. Osteo-
clasts numbers were measured by TRACP activity. Bone resorption was
evaluated by CTX-I and calcium release. The osteoblastic cell line 2T3
was treated with 50% of CM or non-CM for 12 days. Bone formation was
assessed by Alizarin Red extraction.
Results: Only CM from mature osteoclasts induced bone formation, while
CM from precursors or mature macrophages failed to do so. Non-resorbing
osteoclasts generated from osteopetrosis patients showed very little
resorption, yet a blunted, but still signiﬁcant ability to induce bone
formation by osteoblasts. Diphyllin and E64 all potently reduced resorp-
tion, while GM6001 did not. Collected CM from all the conditions induced
bone formation signiﬁcantly compared to their corresponding non-CM,
with an 800% induction by vehicle CM. However, CM from diphyllin,
cathepsin K inhibitor and E64 treated osteoclasts decreased the level of
bone formation compared to CM from vehicle treated osteoclasts by
approximately 50%, while CM from GM6001 treated osteoclasts equaled
vehicle CM. Osteoclasts on either dentine or decalciﬁed bone showed
strongly attenuated anabolic capacities.
Conclusion: We present evidence that osteoclasts, both dependent and
independent of their resorptive activity, secrete activities stimulating
osteoblastic bone formation. Further understanding of these processes
could shed light on the complicated interactions occuring in the sub-
chondral plate during osteoarthritis.
